AA
Addison Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $43K | Sell |
340
-35
| -9% | -$4.43K | 0.01% | 426 |
|
2025
Q1 | $48K | Buy |
375
+35
| +10% | +$4.48K | 0.01% | 393 |
|
2024
Q4 | $45K | Hold |
340
| – | – | 0.01% | 400 |
|
2024
Q3 | $49.5K | Sell |
340
-5
| -1% | -$728 | 0.01% | 394 |
|
2024
Q2 | $47.4K | Sell |
345
-5
| -1% | -$686 | 0.02% | 383 |
|
2024
Q1 | $48K | Sell |
350
-23
| -6% | -$3.16K | 0.02% | 370 |
|
2023
Q4 | $50.7K | Sell |
373
-13
| -3% | -$1.77K | 0.02% | 356 |
|
2023
Q3 | $47.2K | Hold |
386
| – | – | 0.02% | 326 |
|
2023
Q2 | $49K | Hold |
386
| – | – | 0.02% | 318 |
|
2023
Q1 | $49.9K | Hold |
386
| – | – | 0.03% | 299 |
|
2022
Q4 | $50.7K | Hold |
386
| – | – | 0.03% | 284 |
|
2022
Q3 | $45K | Hold |
386
| – | – | 0.03% | 276 |
|
2022
Q2 | $45K | Sell |
386
-75
| -16% | -$8.74K | 0.03% | 270 |
|
2022
Q1 | $60K | Sell |
461
-52
| -10% | -$6.77K | 0.03% | 259 |
|
2021
Q4 | $78K | Buy |
513
+28
| +6% | +$4.26K | 0.05% | 205 |
|
2021
Q3 | $78K | Hold |
485
| – | – | 0.06% | 150 |
|
2021
Q2 | $79K | Buy |
+485
| New | +$79K | 0.06% | 146 |
|
2020
Q4 | $73K | Buy |
+485
| New | +$73K | 0.07% | 148 |
|